Acadian Asset Management
VIGL

Acadian Asset Management’s Vigil Neuroscience VIGL Stock Holding History

Acadian Asset Management’s Portfolio VIGL Stock Details VIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-35,555
Closed -$62K – 1845
2025
Q1 		$62K Sell
35,555
-2,350
-6% -$5.28K ﹤0.01% 1412
2024
Q4 		$63K Buy
+37,905
New +$112K ﹤0.01% 1428
2024
Q3 		– Sell
-6,598
Closed -$26K – 2356
2024
Q2 		$26K Buy
+6,598
New +$22.6K ﹤0.01% 1661

Other funds holding VIGL

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return

Acadian Asset Management's VIGL Position: Q2 2025 in Review

Acadian Asset Management sold out of Vigil Neuroscience (VIGL) in Q2 2025, closing a stake of 35,555 shares — an estimated $62K sold.

Acadian Asset Management first reported a position in VIGL in Q2 2024 and held it in 3 quarters. The position peaked at $63K in Q4 2024. 78 funds tracked by Wall St. Rank hold VIGL as of Q2 2025.

  • Acadian Asset Management reported no remaining Vigil Neuroscience position as of Q2 2025 after selling out during the quarter.
  • Acadian Asset Management sold 35,555 Vigil Neuroscience shares in Q2 2025, an estimated $62K.
  • Acadian Asset Management first reported a position in Vigil Neuroscience in Q2 2024 and held it in 3 quarters.
  • Acadian Asset Management's Vigil Neuroscience position peaked at $63K in Q4 2024.
  • 78 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q2 2025.

Based on Acadian Asset Management's 13F filing for Q2 2025, filed 7 Aug 2025.